PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+8.31%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(-14%)
Cap. Flow
-$66.6M
Cap. Flow
% of AUM
-16.84%
Top 10 Holdings %
Top 10 Hldgs %
40.77%
Holding
93
New
11
Increased
18
Reduced
29
Closed
19
Top Buys
| 1 |
AbbVie
ABBV
|
$8.09M |
| 2 |
Fulcrum Therapeutics
FULC
|
$5.43M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.67M |
| 4 |
Immunic
IMUX
|
$4.51M |
| 5 |
Amgen
AMGN
|
$4.25M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$18M |
| 2 |
Charles River Laboratories
CRL
|
$11.2M |
| 3 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$7.96M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$5.93M |
Sector Composition
| 1 | Healthcare | 97.83% |
| 2 | Industrials | 0.81% |
| 3 | Technology | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Xenon Pharmaceuticals
XENE
$2.99B
| $4.76M | 1.2% |
311,207
-90,000
| -22% | -$1.38M |
|
27
Dentsply Sirona
XRAY
$2.77B
| $4.67M | 1.18% |
80,455
-30,000
| -27% | -$1.74M |
|
28
Ionis Pharmaceuticals
IONS
$9.64B
| $4.57M | 1.16% |
136,380
| – | – |
|
29
Maravai LifeSciences
MRVI
$341M
| $4.42M | 1.12% |
90,000
| – | – |
|
|
30
Amgen
AMGN
$153B
| $4.25M | 1.08% |
+20,000
| New | +$4.25M |
|
|
DRNA
31
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.23M | 1.07% |
209,686
-95,000
| -31% | -$1.92M |
|
32
Azenta
AZTA
$1.35B
| $4.09M | 1.04% |
+40,000
| New | +$4.09M |
|
|
PHLT
33
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $3.87M | 0.98% |
977,334
+480,000
| +97% | +$1.9M |
|
34
Kodiak Sciences
KOD
$453M
| $3.52M | 0.89% |
36,702
| – | – |
|
35
Harvard Bioscience
HBIO
$21.1M
| $3.32M | 0.84% |
475,367
+73,000
| +18% | +$510K |
|
|
RCM
36
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.19M | 0.81% |
+145,000
| New | +$3.19M |
|
37
Axogen
AXGN
$718M
| $3.16M | 0.8% |
200,000
-37,652
| -16% | -$595K |
|
38
Semler Scientific
SMLR
$429M
| $3.13M | 0.79% |
+24,998
| New | +$3.13M |
|
39
Sutro Biopharma
STRO
$85.6M
| $3.09M | 0.78% |
163,389
| – | – |
|
40
Alphatec Holdings
ATEC
$2.35B
| $3.05M | 0.77% |
+250,000
| New | +$3.05M |
|
|
BCYC
41
Bicycle Therapeutics
BCYC
$492M
| $2.89M | 0.73% |
69,549
-11,290
| -14% | -$470K |
|
42
89bio
ETNB
$1.37B
| $2.86M | 0.72% |
145,848
+10,000
| +7% | +$196K |
|
43
Inotiv
NOTV
$54.3M
| $2.85M | 0.72% |
97,500
-17,500
| -15% | -$512K |
|
44
ANI Pharmaceuticals
ANIP
$2.06B
| $2.8M | 0.71% |
85,346
+30,000
| +54% | +$985K |
|
45
BridgeBio Pharma
BBIO
$9.91B
| $2.72M | 0.69% |
57,978
| – | – |
|
46
Supernus Pharmaceuticals
SUPN
$2.52B
| $2.68M | 0.68% |
100,415
| – | – |
|
|
SIEN
47
DELISTED
Sientra, Inc.
SIEN
| $2.53M | 0.64% |
441,746
+140,000
| +46% | +$802K |
|
48
Health Catalyst
HCAT
$228M
| $2.53M | 0.64% |
50,515
| – | – |
|
49
Madrigal Pharmaceuticals
MDGL
$9.7B
| $2.51M | 0.63% |
31,393
-5,000
| -14% | -$399K |
|
50
Outset Medical
OM
$245M
| $2.49M | 0.63% |
50,336
-20,000
| -28% | -$989K |
|